GlaxoSmithKline company profile Francis Weyzig Amsterdam‚ October 2004 Summary Business description GlaxoSmithKline (GSK) is one of the world’s largest research-based pharmaceutical corporations that discovers‚ develops‚ manufactures and markets branded human health products. Headquarters: UK‚ with additional operational headquarters in the USA Global presence: about 160 countries Primary markets: USA‚ France‚ Germany‚ UK‚ Italy and Japan Employees: approximately 103‚000 GSK key figures
Premium Pharmaceutical industry
Coban Subhashini Reddy Merck & Company :Evaluating a Drug Licensing Opportunity • Background - Merck & Company : •In 2000‚ it was a global research-driven pharmaceutical company that discovers‚ develop‚ manufactures and markets a broad range of human and animal health products‚ directly and through its joint ventures‚ and provides pharmaceutical benefit management services through Merck-Medco Managed Care. •Since 1995 ‚ it has launched 15 new products like Vioxx (treats osteoarthritis)‚ Fosamax(treats
Premium Clinical trial Decision tree Expected value
The pharmaceutical industry is the part of the healthcare sector that deals with medications. The industry comprises different subfields pertaining to the development‚ production‚ and marketing of medications. The main goal of the pharmaceutical industry is to provide drugs that prevent infections‚ maintain health‚ and cure diseases. This industry directly affects the global population‚ so a number of international regulatory bodies to monitor things like drug safety‚ patents‚ quality‚ and pricing
Premium Pharmacy Pharmacology Corporate social responsibility
GlaxoSmithKline (GSK) is one of the largest and most profitable pharmaceutical companies in the world. This conglomerate is the product of multiple mergers of some of the leading companies in the industry. It was created in 2000 and at the time this case was written‚ had a market capitalization of $193.5 billion. The company’s most recent focus is on emerging markets‚ vaccines and consumer healthcare. When Sir Andrew Witty took over as CEO in 2008‚ he implemented a significant restructuring program
Premium Vaccine Pharmacology Pharmaceutical industry
However‚ in 1983‚ the FDA requested an intentional suspension on DTC advertising due to not having enough policy regarding advertisements‚ but in 1985‚ the ban got lifted. Nonetheless‚ based upon advertisement by pharmaceutical companies‚ regulations were established to require pharmaceutical companies to advise their consumers
Premium Pharmacology Pharmaceutical drug United States
The drug was a maintenance medication for painful conditions such as arthritis. Maintenance drugs became highly desired by pharmaceutical companies due too long term profitability resulting from no cure CITATION Law14 \l 1033 (Lawerence & Weber‚ 2014). Vioxx was prescribed to over twenty million people in the United States. Merck posted a seven billion dollar profit in a single
Premium Pharmacology Pharmaceutical drug Drug
the clinical condition and if his current medication regime is appropriate for him or if any changes are required. Hence‚ the pharmaceutical care plan may not be tailored to the needs of the patient. Also‚ due to his dossette boxes being delivered to his home there is an increased risk that medication could be lost or delivered to the wrong address (General Pharmaceutical Council‚ 2015‚ 2015). There are many risks associated with providing services at a distant therefore‚ it becomes even more important
Premium Pharmacy Patient Pharmacology
A Project Report On A Global Overview Of A FAST RELIEF Market Submitted in Partial fulfillment for the requirement of the Degree of Master of Business Administration (International Business) from SUS College of engineering and technology‚Tangori‚ Mohali.. Under the Guidance of: Submitted to: Mr. SUNIL Mr. ANIL Mr. PANKAJ SIR Submitted By: NANCY
Premium Pharmaceutical industry Drug discovery
Background of the company and form of organization: RPG Life Sciences (RPGLS) is an Indian Pharmaceutical Company. Formerly known as Searle (India) Ltd‚ RPG Life Sciences is part of RPG Enterprises. It has its corporate office in RPG House in Worli‚ Mumbai. Its three major activities are manufacturing and marketing of bulk drugs‚ also known as API‚ (Active Pharmaceutical Ingredients)‚ pharmaceutical formulation and fermentation & biotechnology. RPGLS is present in the domestic as well as the international
Premium Marketing Pharmacology Pharmaceutical industry
Background The Medicines Company’s business model is to acquire or lease products in the development stage from leading pharmaceutical companies. Essentially‚ they will acquire or lease drugs that have been abandoned or shelved due to lack of early stage research results. The company’s success lays on their being able to save "rejected" compounds‚ receive FDA approval for their use‚ and still turn a profit. This case study provides a look at the first few years of this start-up company‚ from the
Premium Marketing Pharmacology Pharmaceutical industry